000 | 01021 a2200289 4500 | ||
---|---|---|---|
005 | 20250515052910.0 | ||
264 | 0 | _c20070621 | |
008 | 200706s 0 0 fre d | ||
022 | _a0370-629X | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLegrand, D A | |
245 | 0 | 0 |
_a[Aspirin for primary prevention of cardiovascular diseases in diabetic patients: focus on gender difference and insulin resistance]. _h[electronic resource] |
260 |
_bRevue medicale de Liege _cOct 2006 |
||
300 |
_a682-90 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aCardiovascular Diseases _xmetabolism |
650 | 0 | 4 |
_aDiabetes Complications _xmetabolism |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInsulin Resistance |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aSex Factors |
700 | 1 | _aScheen, A J | |
773 | 0 |
_tRevue medicale de Liege _gvol. 61 _gno. 10 _gp. 682-90 |
|
999 |
_c16775432 _d16775432 |